More on LTRN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lantern Pharma (NQ:LTRN)
Delayed: 1.94 -0.08 (3.96%)
Prev. Close $2.02  
Open$2.05 
52 Wk High$ 
52 Wk Low$ 
Day High$2.10 
Day Low$1.90 
P/E N/A  
EPS$ 
Volume156,206 

Friends, Peers and Foes (?): DVLT, CAST, RDZN, BSIN, MDCX (more...)

Aug 29, 2026 09:23 AM New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (S
Aug 14, 2026 07:36 AM Form 8-K Lantern Pharma Inc. For: Aug 14
Aug 14, 2026 07:31 AM Form 10-Q Lantern Pharma Inc. For: Jun 30
Aug 14, 2026 07:30 AM Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 8, 2026 12:01 PM New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results
Aug 7, 2026 08:00 AM Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET
Aug 4, 2026 10:04 AM Form SCHEDULE 13G Lantern Pharma Inc. Filed by: Empery Asset Management, LP
Aug 3, 2026 05:25 PM Form 8-K Lantern Pharma Inc. For: Aug 03
Aug 3, 2026 07:31 AM Lantern Pharma spins out AI platform into separate company
Aug 3, 2026 07:30 AM Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine
View All Articles

Entities mentioned with LTRN

View All Entities